跳至主要内容
临床试验/CTRI/2022/01/039863
CTRI/2022/01/039863已完成2 期

Preclinical and clinical evaluation of the effect on oral administration of KARUNJEERAKA MATHIRAI along with external application of NUNAA TAILAM in the management of VENPADAI in children

Dr S Surendar1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年4月2日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Reduction in clinical symptoms 45 days

研究概览

简要总结

It is a single arm trial for preclinical and clinical evaluation of effect on oral administration of KARUNJEERAKA MATHIRAI along with external application of NUNAA TAILAM in the management of VENPADAI in children

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
3.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • 1.Hypo pigemented patches surrounded by hyper pigemneted border present in any part of the body.

排除标准

  • 1.Children above 12 years 2.Children below 3 years 3.Albinism 4.Pie-baldism 5.Hypo pigmented patches start firstly in lips and genital area 6.Depigemented patches after burns 7.Juvenile diabetes with vitiligo.

结局指标

主要结局

Reduction in clinical symptoms 45 days

时间窗: Reduction in clinical symptoms 45 days

次要结局

未报告次要终点

研究者

发起方
Dr S Surendar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验